2021
DOI: 10.1007/s11060-020-03664-9
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(17 citation statements)
references
References 19 publications
1
13
0
3
Order By: Relevance
“…Among RCTs ( n = 10), “refractory” epilepsy was used in seven studies 13,15,21,22,25,28,35 . Additionally, five studies also used the term “adjunctive” or “adjunctive therapy” to describe the intervention 14,16,27,29,31 .…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Among RCTs ( n = 10), “refractory” epilepsy was used in seven studies 13,15,21,22,25,28,35 . Additionally, five studies also used the term “adjunctive” or “adjunctive therapy” to describe the intervention 14,16,27,29,31 .…”
Section: Resultsmentioning
confidence: 99%
“…Three studies also used the term “uncontrolled” or “not adequately controlled,” referring to seizures 23,24,26 . Among non‐RCTs ( n = 23), “refractory” epilepsy was used in 15 studies 13,15,17,18,21,22,28,30,33–35,39,40,42,43 . Two studies specifically highlighted “medically refractory epilepsy” 38 and “treatment‐resistant epilepsy.” 14 Four studies did not specifically define DRE 37,41,44,45 .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations